Pharmacokinetic and Pharmacodynamic Evaluation of the Potential Drug Interaction Between Venlafaxine and Diazepam
- 1 April 1995
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 35 (4) , 410-419
- https://doi.org/10.1002/j.1552-4604.1995.tb04082.x
Abstract
To assess possible pharmacokinetic and pharmacodynamic interactions between the antidepressant venlafaxine and diazepam, a randomized, two‐period, crossover study was conducted in 18 men. Multiple‐dose venlafaxine (50 mg every 8 hours) or placebo (double‐blind) was given for 10 days; on day 4 a single placebo dose (same appearance as diazepam capsule, single‐blind) was given; and on day 5 a single dose of diazepam (10 mg) was given. Pharmacokinetic data indicated that diazepam had no significant effect on venlafaxine or O‐desmethylvenlafaxine disposition. Diazepam pharmacokinetics were minimally changed in the presence of venlafaxine. Diazepam oral clearance (CL/f) increased slightly (24 ± 8 versus 26 ± 6 mL/h/kg; P = .007), volume of distribution (Vz/f) increased (0.85 ± 0.28 versus 0.99 ± 0.34 L/kg; P = .02), and AUC decreased (5973 ± 2304 versus 5008 ± 1354 ng • h/mL; P = .02). Venlafaxine did not alter desmethyldiazepam pharmacokinetics. Pharmacodynamic data showed a statistically significant diazepam—venlafaxine interaction for only one of the eight psychometric tests given. Critical flicker fusion slightly decreased (P = .01) between placebo—diazepam (37.85 ± 3.28 Hz) and venlafaxine—diazepam (37.09 ± 4.13 Hz) treatments. The observed pharmacokinetic and pharmacodynamic interactions between diazepam and venlafaxine were small and probably clinically insignificant.Keywords
This publication has 17 references indexed in Scilit:
- Introduction of a Composite Parameter to the Pharmacokinetics of Venlafaxine and its Active O‐Desmethyl MetaboliteThe Journal of Clinical Pharmacology, 1992
- Biochemical, neurophysiological, and behavioral effects of Wy‐45,233 and other identified metabolites of the antidepressant venlafaxineDrug Development Research, 1991
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987
- Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivativeBiochemical Pharmacology, 1986
- Effects of alprazolam and diazepam on the daytime sleepiness of non-anxious subjectsPsychopharmacology, 1985
- Dose-response analysis of the behavioral effects of diazepam: I. Learning and memoryPsychopharmacology, 1984
- Mini-computer programs for bioequivalence testing of pharmaceutical drug formulations in two-way cross-over studies: Including a survey of current parametric evaluation techniquesComputer Programs in Biomedicine, 1983
- Influence of cimetidine on oral diazepam elimination with measurement of subsequent cognitive change.British Journal of Clinical Pharmacology, 1982